| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.46 | 9e-09 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-06 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-06 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.12 | 3e-05 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.0007 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.001 |